Two motivations drove the recent marriage of Hazelden and the Betty Ford Center, addiction treatment giants whose network spans 15 care sites in nine states.
By joining together, the institutions think they will be able to run more efficiently, with greater capital investment capabilities. But they also aim to position themselves to capture a greatly expanded market, as the Affordable Care Act requires insurance coverage for drug and alcohol abuse treatment.
"The general perception is that under the ACA there will be a big new market for addiction treatment," said Dan Cain, president of the Twin Cities-based substance abuse treatment program RS Eden.
Combining Hazelden, which is based in Center City, 45 miles northeast of Minneapolis, with the California-based Betty Ford Center probably was not necessary for either institution to succeed under the ACA, said Leemore Dafny, a professor of management and strategy at Northwestern University. The merger, she explained, looks to be a continuation of a national trend in health care in which organizations join forces to "expand their regional and national footprint."
For patients and taxpayers, the Hazelden-Betty Ford merger illustrates the delicate balance that must be struck between economic effectiveness and costs of care, said Eric Campbell, research director at the Mongan Institute for Health Policy at Harvard Medical School.
"To the extent that you can combine and lower overhead, I could see how you could get efficiencies while keeping the quality," Campbell said. "The question is where do mergers become anticompetitive" by monopolizing markets.
In the case of addiction treatment, there appears to be a big untapped market.
Before health care reform, studies showed that roughly 80 to 90 percent of those with alcoholism and drug problems were not being served, many because they had no health insurance or the insurance they had limited mental health coverage.